Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Catherine Liebig Akay"'
Autor:
Mark V. Schaverien, Patrick B. Garvey, Rosa F. Hwang, Anaeze C. Offodile nd, Malke Asaad, Stefanos Boukovalas, Catherine Liebig Akay, Jun Liu
Publikováno v:
Journal of the American College of Surgeons. 233(3)
Financial toxicity (FT) can lead to decreased quality of life and poor treatment outcomes. However, there is limited published data on the extent to which the various surgical treatment approaches for early-stage breast cancer are determinants for FT
Autor:
Cristina M. Checka, Joanna Lee, Lumarie Santiago, Jessica S. Colen, Robert J. Volk, Henry Mark Kuerer, Dalliah M. Black, Elsa Arribas, Catherine Liebig Akay, Abigail S. Caudle
Publikováno v:
J Surg Oncol
PURPOSE: To evaluate the acceptability and impact of 3D printed breast models (3D-BM) on treatment-related decisional conflict (DC) of breast cancer patients. METHODS: Patients with breast cancer were accrued in a prospective IRB-approved trial. All
Autor:
Anthony Lucci, Catherine Liebig Akay, Elizabeth A. Mittendorf, Wendy A. Woodward, Wei Yang, Savitri Krishnamurthy, Sarah M. DeSnyder, Carissa Le-Petross, Gary J. Whitman, Naoto T. Ueno, Gildy Babiera, Henry Mark Kuerer
Publikováno v:
Clinical Breast Cancer. 18:e73-e77
Background Most inflammatory breast cancer (IBC) patients have axillary disease at presentation. Current standard is axillary lymph node dissection (ALND) after neoadjuvant chemotherapy (NACT). Advances in NACT have improved pathologic complete respo
Autor:
Lei Huo, Yun Wu, Catherine Liebig Akay, Yi Jue Zhao, Gildy Babiera, Susan C. Abraham, Xinyan Lu, De Bing Xiang, Abigail S. Caudle, Constance Albarracin, Pulivarthi Rao, Hong Zhang, Bing Wei
Publikováno v:
Human Pathology. 45:1951-1956
Summary Primary mammary neuroendocrine carcinoma (NEC) is an uncommon entity that accounts for 2% to 5% of breast carcinomas. Recent reports have shown that NEC of the breast is an aggressive subtype of mammary carcinoma that is distinct from invasiv
Autor:
Lei Huo, Isabelle Bedrosian, Gabriel N. Hortobagyi, H. M. Kuerer, Ricardo H. Alvarez, Naoto T. Ueno, Wendy Woodward, Catherine Liebig Akay, Gildy Babiera, Kelly K. Hunt, Gary B. Chisholm
Publikováno v:
Cancer. 120:1319-1328
BACKGROUND To the authors' knowledge, the benefit of primary tumor resection among patients with metastatic inflammatory breast cancer (IBC) is unknown. METHODS The authors reviewed 172 cases of metastatic IBC. All patients received chemotherapy with
Autor:
Cristina M. Checka, Kelly K. Hunt, Rosa F. Hwang, John Terrell, Abigail S. Caudle, Chantal Reyna, Alastair M. Thompson, Anthony Lucci, Mediget Teshome, Merrick I. Ross, Ko Un Park, Kristin Kyrish, Sarah M. DeSnyder, Ana Paula Refinetti, Funda Meric-Bernstam, Barry W. Feig, Dalliah M. Black, Isabelle Bedrosian, Catherine Liebig Akay, Henry Mark Kuerer
Publikováno v:
Journal of Clinical Oncology. 36:e18799-e18799
e18799Background: Post-operative analgesia requirements vary, but no guidelines exist for opioid prescription (Rx) after breast surgical oncology (BSO) procedures. Given the national opioid epidemi...
Autor:
Eric A. Strom, George H. Perkins, Karen E. Hoffman, Wendy A. Woodward, Vinita Takiar, Gildy Babiera, Catherine Liebig Akay, Ricardo H. Alvarez, Thomas A. Buchholz, Naoto T. Ueno, Michael C. Stauder, Welela Tereffe
Publikováno v:
SpringerPlus
Introduction Definitive locoregional therapy including surgery and post-mastectomy radiation therapy (PMRT) has been offered to select IBC patients with de novo metastatic disease. Herein we examined predictive factors for progression-free survival a
Autor:
Kelly K. Hunt, Susan L. Tucker, Funda Meric-Bernstam, Gildy Babiera, Thomas A. Buchholz, Karen E. Hoffman, Henry Mark Kuerer, Eric A. Strom, Elizabeth G. Grubbs, Elizabeth A. Mittendorf, Catherine Liebig Akay, Isabelle Bedrosian
We previously developed a prognostic index for assessing local-regional recurrence (LRR) risk in patients undergoing breast conservation therapy (BCT) after neoadjuvant chemotherapy. The prognostic index assigns a point for each of the following vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508ba3e7e876e8deede8a75dd15f651c
https://europepmc.org/articles/PMC6086605/
https://europepmc.org/articles/PMC6086605/
Autor:
Ricardo H. Alvarez, Wendy A. Woodward, Kelly K. Hunt, Gabriel N. Hortobagyi, Gildy Babiera, Catherine Liebig Akay, Lei Huo, Anthony Lucci, Henry Mark Kuerer, Isabelle Bedrosian, Naoto T. Ueno, Gary B. Chisholm
Publikováno v:
Journal of Clinical Oncology. 30:1102-1102
1102 Background: Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer typically presenting with early metastasis. Optimal outcomes are achieved with multimodality treatment strategies in the non-metastatic setting. Data is